Zomedica Corp.
corporate_fare Company Profile
Zomedica Corp. (OTC:ZOMDF) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 3 items for ZOMDF at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-05-06, rated 8/10. Across its 3 most recent items scored 7 or higher, the top rating is 9/10, with 2 rated 8 or above. Recent SEC coverage for ZOMDF spans PRE 14A, 10-K.
Recent high-impact activity:
- Zomedica Posts 35% Q1 Revenue Growth to $8.8M, Significantly Cuts Net Loss
- Zomedica Faces Shareholder Dissent on Executive Pay, Proposes By-Law Change to Facilitate Meetings Amid Low Engagement
- Zomedica Reports NYSE American Delisting and $55.8M Impairment Amid Widening Losses in 2025 Annual Report
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 126,253 shares in ZOMDF as of the September 15, 2026 settlement, unchanged from the prior period — about 1.0 days to cover at its recent average daily volume. On October 2, 2026, 19.0% of ZOMDF volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.